Audet & Partners, LLP reports that the U.S. Food and Drug Administration (FDA) has issued new formal guidelines that are intended to clarify whether certain changes to marketed medical devices constitute a "recall" or "product enhancement."[...]
Archive
Tag: FDA Guidance